Literature DB >> 15967717

Control of peripheral T-lymphocyte tolerance in neonates and adults.

Bernd Arnold1, Thomas Schüler, Günter J Hämmerling.   

Abstract

Neonatal life is a unique developmental stage, in which the peripheral T-lymphocyte pool is evolving in a lymphopenic environment and the freshly generated T lymphocytes are extensively migrating through non-lymphoid tissues. Here, we emphasize the consequences of neonatal lymphopenia and tissue accessibility for T-lymphocyte tolerance induction. We propose that self-destructive T-lymphocyte responses are prevented in the neonate by limiting homeostatic T-lymphocyte expansion and thereby the activation of potentially autodestructive memory T lymphocytes. Furthermore, the extensive migration through tissues might lead to a dominant form of tolerance in the neonatal phase, which is maintained throughout adult life, during which the tissues are no longer readily accessible to T lymphocytes. Thus, it is not only dendritic cells that are crucial for self-tolerance: neonatal mechanisms are also required.

Entities:  

Mesh:

Year:  2005        PMID: 15967717     DOI: 10.1016/j.it.2005.06.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  10 in total

1.  Effects of microflora on the neonatal development of gut mucosal T cells and myeloid cells in the mouse.

Authors:  Amanda M Williams; Christopher S J Probert; Renata Stepankova; Helena Tlaskalova-Hogenova; Anne Phillips; Paul W Bland
Journal:  Immunology       Date:  2006-09-21       Impact factor: 7.397

Review 2.  The role of the changing human microbiome in the asthma pandemic.

Authors:  Timothy C Borbet; Xiaozhou Zhang; Anne Müller; Martin J Blaser
Journal:  J Allergy Clin Immunol       Date:  2019-12       Impact factor: 10.793

3.  Tolerance rather than immunity protects from Helicobacter pylori-induced gastric preneoplasia.

Authors:  Isabelle C Arnold; Josephine Y Lee; Manuel R Amieva; Axel Roers; Richard A Flavell; Tim Sparwasser; Anne Müller
Journal:  Gastroenterology       Date:  2010-06-22       Impact factor: 22.682

4.  Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10.

Authors:  Daniela B Engler; Sebastian Reuter; Yolanda van Wijck; Sabine Urban; Andreas Kyburz; Joachim Maxeiner; Helen Martin; Nir Yogev; Ari Waisman; Markus Gerhard; Timothy L Cover; Christian Taube; Anne Müller
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-29       Impact factor: 11.205

Review 5.  Helicobacter pylori: Does Gastritis Prevent Colitis?

Authors:  Isabelle C Arnold; Anne Müller
Journal:  Inflamm Intest Dis       Date:  2016-05-13

6.  Thymocytes may persist and differentiate without any input from bone marrow progenitors.

Authors:  Laetitia Peaudecerf; Sara Lemos; Alessia Galgano; Gerald Krenn; Florence Vasseur; James P Di Santo; Sophie Ezine; Benedita Rocha
Journal:  J Exp Med       Date:  2012-07-09       Impact factor: 14.307

Review 7.  The Immunomodulator VacA Promotes Immune Tolerance and Persistent Helicobacter pylori Infection through Its Activities on T-Cells and Antigen-Presenting Cells.

Authors:  Aleksandra Djekic; Anne Müller
Journal:  Toxins (Basel)       Date:  2016-06-16       Impact factor: 4.546

Review 8.  Lymphopenia, Lymphopenia-Induced Proliferation, and Autoimmunity.

Authors:  Ting-Ting Sheu; Bor-Luen Chiang
Journal:  Int J Mol Sci       Date:  2021-04-16       Impact factor: 5.923

9.  Marked liver tumorigenesis by Helicobacter hepaticus requires perinatal exposure.

Authors:  Bhalchandra A Diwan; Marek Sipowicz; Daniel Logsdon; Peter Gorelick; Miriam R Anver; Kazimierz S Kasprzak; Lucy M Anderson
Journal:  Environ Health Perspect       Date:  2008-06-13       Impact factor: 9.031

10.  Premature CD4+ T cell aging and its contribution to lymphopenia-induced proliferation of memory cells in autoimmune-prone non-obese diabetic mice.

Authors:  Ting-Ting Sheu; Bor-Luen Chiang; Jui-Hung Yen; Wen-Chi Lin
Journal:  PLoS One       Date:  2014-02-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.